SPOTFIRE Sore Throat (ST) Study
Completed · Not applicable · NCT06713642
Conditions: Pharyngitis, Infective
At a glance
- Research payments reported, 2025
- $40,300
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 200
About the trial
- Sponsor
- University of Wisconsin, Madison (with BioMérieux)
- Tested
- SPOTFIRE ST System (device)
- Dates
- Started 2024-12-02; completion 2025-03-31
- Results posted
- Yes
The purpose of this study is to evaluate where urgent care (UC) clinicians see the most benefit for a novel, point of care pharyngitis test, SPOTFIRE ST, and describe its performance, potential clinical utility, and satisfaction of providers and patients with this novel test. Up to 200 participants will be on study for up to approximately 25 minutes.
From ClinicalTrials.gov, last updated 2026-03-23. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Biomerieux Inc reported $40,300 in research payments for this study in 2025 (1 payments).
Products named: Biofire Spotfire Respiratory/sore Throat (r/st) PAnel
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- The Board of Regents of the University of Wisconsin System $40,300
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.